BioCorRx Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
BioCorRx Inc. (BICX) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.36 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-03-31
- BioCorRx Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2025-03-31 was $0.43, a 50.57% decline year-over-year.
- BioCorRx Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-31 was $0.87, a 50.85% decline year-over-year.
- BioCorRx Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was $1.77, a 54.50% decline year-over-year.
- BioCorRx Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2022-03-31 was $3.89.
- BioCorRx Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $0.36, a 10.00% decline from fiscal 2024.
- BioCorRx Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $0.40, a 77.14% decline from fiscal 2023.
- BioCorRx Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $1.75, a 43.00% decline from fiscal 2022.
- BioCorRx Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $3.07.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $0.36 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $0.39 10-Q · filed 2025-11-14 | ||||
| 2025-06-30 | $0.39 10-Q · filed 2025-08-14 | ||||
| 2025-03-31 | $0.43 10-Q · filed 2025-05-15 | ||||
| 2024-12-31 | $0.40 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | $0.52 10-Q · filed 2024-11-14 | ||||
| 2024-06-30 | $0.67 10-Q · filed 2024-08-13 | ||||
| 2024-03-31 | $0.87 10-Q · filed 2024-05-15 | ||||
| 2023-12-31 | $1.75 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $1.75 10-Q · filed 2023-11-14 | ||||
| 2023-06-30 | $1.75 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | $1.77 10-Q · filed 2023-05-15 | ||||
| 2022-12-31 | $3.07 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $3.85 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | $3.93 10-Q · filed 2022-08-15 | ||||
| 2022-03-31 | $3.89 10-Q · filed 2022-05-16 | ||||
| 2021-12-31 | $0.00 10-K · filed 2022-03-31 | ||||
| 2020-12-31 | $2.53 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $3.00 10-Q · filed 2020-11-16 | ||||
| 2019-12-31 | $6.52 10-K · filed 2021-03-31 | ||||
| 2019-06-30 | $6.52 10-Q · filed 2019-08-14 | ||||
| 2018-12-31 | $14.00 10-K · filed 2020-03-30 | ||||
| 2018-06-30 | $0.14 10-Q · filed 2018-08-14 | ||||
| 2017-12-31 | $1.60 10-K · filed 2019-04-16 | $0.02 10-K · filed 2018-04-05 | |||
| 2017-09-30 | $0.02 10-Q · filed 2017-11-14 | ||||
| 2016-12-31 | $0.02 10-K · filed 2018-04-05 | ||||
| 2015-12-31 | $0.07 10-K · filed 2017-04-13 | ||||
| 2014-12-31 | $0.25 10-Q · filed 2015-11-16 | ||||
| 2012-12-31 | $0.01 10-Q · filed 2013-05-15 |